1,3-Benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-(pentyl-5,5,5-d3)-

Request For Quotation
1,3-Benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-(pentyl-5,5,5-d3)- Basic information
Product Name:1,3-Benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-(pentyl-5,5,5-d3)-
Synonyms:1,3-Benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-(pentyl-5,5,5-d3)-;Cannabidiol-d3 (CRM);Cannabidiol-D3, 1mg/ml in Methanol;Cannabidiol-D3, 0.1mg/ml in Methanol
CAS:1435783-16-6
MF:C21H30O2
MW:314.47
EINECS:
Product Categories:
Mol File:1435783-16-6.mol
1,3-Benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-(pentyl-5,5,5-d3)- Structure
1,3-Benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-(pentyl-5,5,5-d3)- Chemical Properties
Safety Information
MSDS Information
1,3-Benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-(pentyl-5,5,5-d3)- Usage And Synthesis
DescriptionCannabidiol-d3 (CRM) (Item No. 33075) is a certified reference material intended for use as an internal standard for the quantification of cannabidiol (Item Nos. ISO60156 | 90080) by GC- or LC-MS. Cannabidiol is categorized as a phytocannabinoid.1 Unlike Δ9-THC, cannabidiol is non-psychoactive. Formulations containing cannabidiol have been used in the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use.
1,3-Benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-(pentyl-5,5,5-d3)- Preparation Products And Raw materials
Tag:1,3-Benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-(pentyl-5,5,5-d3)-(1435783-16-6) Related Product Information
(-)-delta-9-Thc (d3) Cannabidiol-d9 Cannabidiolic Acid-d3 (CRM) CANNABIDIOL